Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 month
- Director since
- 2026
1 month of board service in total across 1 board, counting each seat separately. Longest: Attovia Therapeutics Inc., 1 month.
Attovia Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Attovia Therapeutics Inc. | Derivative conversion | +1,957,134 | — | — |
| Aug 6, 2026 | Attovia Therapeutics Inc. | Derivative conversion | +478,498 | — | — |
| Aug 6, 2026 | Attovia Therapeutics Inc. | Open-market purchase | +500,000 | $17.00 | $8,500,000 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market purchase | +85,000 | $21.00 | $1,785,000 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −988 | $22.03 | $21,766 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −447 | $21.87 | $9,776 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −1,332 | $22.03 | $29,344 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −200 | $22.05 | $4,410 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −1,556 | $22.06 | $34,325 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −3,402 | $22.02 | $74,912 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −200 | $22.10 | $4,420 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −480 | $21.55 | $10,344 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −100 | $22.11 | $2,211 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −753 | $21.97 | $16,543 |
| Aug 5, 2026 | Attovia Therapeutics Inc. | Open-market sale | −672 | $22.02 | $14,797 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.